APGE Apogee Therapeutics, Inc.
Biotechnology NasdaqGM
Trading Signals
Overall Signal
BUY
Strong buyish signal based on multiple indicators.
Key Price Levels
Support Levels
- Strong Support $36.37
- Medium Support $38.7
- Weak Support $41.04
Resistance Levels
- Weak Resistance $45.72
- Medium Resistance $48.06
- Strong Resistance $50.39
Stop Loss Suggestions
- Conservative $40.7
- Moderate $39.87
- Aggressive $37.54
Analyst Ratings
Current Rating
Last Month
2 Months Ago
3 Months Ago
Signal Indicator
| Indicator | Signal | Strength | Timeframe |
|---|---|---|---|
| Moving Averages | BUY |
|
Short & Medium Term |
| Oscillators | BUY |
|
Short Term |
| Trend Indicators | BUY |
|
Medium Term |
| Volume Indicators | SELL |
|
Short & Medium Term |
| Support/Resistance | NEUTRAL |
|
Short Term |
Stock Price Prediction Price Target Probabilities
Quarterly Outlook
2025-06-28
Bullish Scenario
from current 31.41%
Strong upward momentum and confirmed bullish trend, with potential for significant price appreciation. Indicators point to sustained buying pressure. ADX (12.68) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (53.75) is in bullish territory, indicating upward momentum. MACD line (-0.22) is above Signal line (-1.35) (bullish crossover), confirming upward momentum. Current Weekly ATR is 5.45, indicating the average weekly price range.
2025-06-28
Base Scenario
from current 6.28%
Price is likely to continue its moderate trajectory, reflecting underlying market conditions and historical volatility. Indicators suggest a balanced outlook. ADX (12.68) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (53.75) is in bullish territory, indicating upward momentum. MACD line (-0.22) is above Signal line (-1.35) (bullish crossover), confirming upward momentum. Current Weekly ATR is 5.45, indicating the average weekly price range.
2025-06-28
Bearish Scenario
from current -25.13%
Increased selling pressure and potential for a significant price correction or downtrend. Indicators suggest waning bullish momentum or strengthening bearish forces. ADX (12.68) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (53.75) is in bullish territory, indicating upward momentum. MACD line (-0.22) is above Signal line (-1.35) (bullish crossover), confirming upward momentum. Current Weekly ATR is 5.45, indicating the average weekly price range.
Annual Outlook
2025-06-28
Bullish Scenario
from current 62.82%
Long-term bullish trend with strong fundamental catalysts and sustained institutional buying. Expect significant capital appreciation over the year. ADX (12.68) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (53.75) is in bullish territory, indicating upward momentum. MACD line (-0.22) is above Signal line (-1.35) (bullish crossover), confirming upward momentum. Current Weekly ATR is 5.45, indicating the average weekly price range.
2025-06-28
Base Scenario
from current 12.56%
Steady long-term growth consistent with market and industry averages. Price expected to follow a typical growth trajectory. ADX (12.68) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (53.75) is in bullish territory, indicating upward momentum. MACD line (-0.22) is above Signal line (-1.35) (bullish crossover), confirming upward momentum. Current Weekly ATR is 5.45, indicating the average weekly price range.
2025-06-28
Bearish Scenario
from current -50.25%
Long-term bearish trend with significant headwinds from economic factors, industry disruption, or company-specific issues. Expect notable price depreciation. ADX (12.68) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (53.75) is in bullish territory, indicating upward momentum. MACD line (-0.22) is above Signal line (-1.35) (bullish crossover), confirming upward momentum. Current Weekly ATR is 5.45, indicating the average weekly price range.
Technical Analysis
Trend Identification
EMA
Exponential Moving Average
Current price (43.38) is above both Short MA (40.93) and Long MA (37.98). This indicates strong bullish momentum. Short MA (40.93) is above Long MA (37.98), a bullish crossover ('Golden Cross' if it's a significant period). This indicates an upward trend. All MAs are in bullish order (Price > Short MA > Long MA > Very Long MA 37.53). This is a strong bullish alignment. Consider long positions. Use the MAs as dynamic support levels.
MACD
Moving Average Convergence Divergence
MACD line is above the Signal line (bullish crossover). This indicates upward momentum. Histogram (0.1400) is positive and expanding, confirming bullish momentum. Both MACD and Signal lines are above the zero line, reinforcing bullish momentum (bullish territory). This is a strong buy signal. Consider long positions.
ADX
Average Directional Index
ADX (20.85) indicates a developing or weakening trend. +DI (21.45) is above -DI (12.11), suggesting a bullish directional bias. Be cautious with current positions. Monitor for trend continuation or reversal signals.
Momentum Measurement
RSI
Relative Strength Index
RSI (59.12) is in the bullish territory, but not yet overbought. This indicates upward momentum. Monitor for continuation or signs of weakness.
OBV
On-Balance Volume
OBV (-6295620.00) is falling, indicating selling pressure and distribution. Price is falling and OBV is falling. This is bearish confirmation, indicating selling pressure supports the price decrease. Consider holding short positions or initiating new ones. Volume is supporting the trend.
Stochastic
Stochastic Oscillator
Stochastics (%K: 72.16, %D: 66.74) are in the neutral zone (between 20 and 80). A bullish crossover (%K above %D) is observed. This indicates upward momentum. Be cautious if it's already in the overbought region.
CCI
Commodity Channel Index
CCI (86.61) is between 0 and +100. This indicates bullish momentum is present, but not yet extreme. A move above 0 from negative territory (bullish zero-line cross) can indicate a potential buy signal.
Volatility Measurement
ATR
Average True Range
Current ATR is 2.3400. ATR indicates average volatility. Market conditions are relatively stable.
Bollinger Bands
Volatility Bands
Current price (43.38) is within the Bollinger Bands (35.78 - 46.08). This suggests the price is trading within its typical volatility range. Price is above the Middle Band (40.93), indicating short-term bullish bias. Bollinger Bands are wide. This indicates high volatility. Prices tend to revert to the mean after extended periods of high volatility.
Risk Management & Potential Reversals
SAR
Parabolic Stop and Reverse
SAR points below price indicate bullish trend. Current SAR at 40.70 is 6.18% from price. Consider SAR as a potential stop-loss level to protect gains in an uptrend.
RSI
Reversal Perspective
Current RSI level is in neutral territory. No RSI divergence detected. Current RSI level doesn't suggest imminent reversal.
Stochastic
Approaching Overbought
Stochastic is approaching overbought territory (72.2). No reversal signal yet. Monitor for potential bearish crossover (K below D) or entry into overbought (80+) followed by reversal. Current crossover status: Bullish.
Bollinger Bands
Reversal Perspective
Bollinger Bands are widening, indicating high volatility and potential strong trend continuation.Price is in the upper half of the bands, suggesting a bullish bias.No indication of imminent volatility expansion or reversal.
Holder List (Top 20)
| Holder Name | Holder Type | Shares | Pct. Held | Date Reported |
|---|---|---|---|---|
| VR Adviser, LLC | INSTITUTIONAL | 8493321 | 18.92% | 2025-03-31 |
| FMR, LLC | INSTITUTIONAL | 7493626 | 16.7% | 2025-03-31 |
| Wellington Management Group, LLP | INSTITUTIONAL | 5485754 | 12.22% | 2025-03-31 |
| Blackrock Inc. | INSTITUTIONAL | 2910829 | 6.49% | 2025-03-31 |
| RTW Investments LP | INSTITUTIONAL | 2712097 | 6.04% | 2025-03-31 |
| Driehaus Capital Management, LLC | INSTITUTIONAL | 2339563 | 5.21% | 2025-03-31 |
| Vanguard Group Inc | INSTITUTIONAL | 2082606 | 4.64% | 2025-03-31 |
| Fairmount Funds Management LLC | INSTITUTIONAL | 2048647 | 4.56% | 2025-03-31 |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | MUTUALFUND | 1999952 | 4.46% | 2025-01-31 |
| Janus Henderson Group PLC | INSTITUTIONAL | 1793833 | 4% | 2025-03-31 |
| Mercer Global Advisors, Inc./ADV | INSTITUTIONAL | 1640180 | 3.65% | 2025-03-31 |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | MUTUALFUND | 1406372 | 3.13% | 2025-04-30 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | MUTUALFUND | 1196478 | 2.67% | 2025-03-31 |
| iShares Trust-iShares Russell 2000 ETF | MUTUALFUND | 932852 | 2.08% | 2025-04-30 |
| T. Rowe Price Health Sciences Fund, Inc. | MUTUALFUND | 587295 | 1.31% | 2025-03-31 |
| JPMorgan Trust II-JPMorgan Small Cap Growth Fund | MUTUALFUND | 540934 | 1.21% | 2025-03-31 |
| VANGUARD EXPLORER FUND | MUTUALFUND | 530576 | 1.18% | 2025-01-31 |
| SPDR SERIES TRUST-SPDR(R) S&P(R) Biotech ETF | MUTUALFUND | 514010 | 1.15% | 2025-04-30 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | MUTUALFUND | 489961 | 1.09% | 2025-03-31 |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | MUTUALFUND | 470123 | 1.05% | 2025-04-30 |